NextGen Launches Protein Biomarker Discovery Panel; Aims to Take Market Share from RBM
March 18, 2011
NextGen Launches Protein Biomarker Discovery Panel; Aims to Take Market Share from RBM
Called plasmadiscover41, the panel comprises 41 plasma proteins thought to be potential biomarkers for various cancers. The company is also working on a 50- to 60-protein panel for CSF biomarkers that it plans to introduce in the second quarter.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Myriad to Enter Proteomics Market with $80M Purchase of Rules-Based Medicine
April 29, 2011 / ProteoMonitor - Merck Uses Phosphoproteomics to Identify Potential Biomarkers for Cancer Drug Development
August 6, 2010 / ProteoMonitor - TGen's Center for Proteomics Named a Waters Center of Innovation
August 26, 2011 / ProteoMonitor - NextGen Inks Deal with University of Nebraska to Use Biomarker Discovery Panel for NeuroAIDS Work
August 19, 2011 / ProteoMonitor - Lund Scientists Develop Immunoaffinity-MS Workflow for Discovery Proteomics
August 12, 2011 / ProteoMonitor